Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase 3 Study With P2B001 in Subjects With Early Parkinson's

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03329508
Recruitment Status : Active, not recruiting
First Posted : November 6, 2017
Last Update Posted : May 21, 2021
Information provided by (Responsible Party):
Pharma Two B Ltd.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 31, 2021
Estimated Study Completion Date : October 31, 2021